Screener
Fulgent Genetics, Inc. FLGT Q2 2025 earnings
Reported August 1, 2025 · Before market open
Revenue$81.8MBeat by $373.0K
EPS$0.07Beat by $0.30
Revenue estimate$81.4M
EPS estimate-$0.23
Next report
Nov 6, 2026 (in 2 months)Revenue estimate$86.3M
EPS estimate-$0.65
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Fulgent Genetics, Inc. report Q2 2025 earnings?
- Fulgent Genetics, Inc. (FLGT) reported Q2 2025 earnings on August 1, 2025 before market open.
- What were Fulgent Genetics, Inc.'s Q2 2025 revenue and EPS?
- Fulgent Genetics, Inc. reported revenue of $81.8M and eps of $0.07 for Q2 2025.
- Did Fulgent Genetics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $81.4M by $373.0K. EPS beat the consensus estimate of $-0.23 by $0.30.
- How did Fulgent Genetics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 15.2% from $71.0M a year earlier and eps declined 53.3% from $0.15.
- Where can I find Fulgent Genetics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-101103) and the 10-Q periodic report (0000950170-25-101105) directly on SEC EDGAR. The filing index links above go to sec.gov.
